ReVital-CORE Program

Completed

Conditions studied: Frailty, Cancer, Chemotherapy-Induced Change

In brief

Pilot feasibility study of the ReVital Chemotherapy Online Resiliency Evaluation (CORE) program. As part of standard of care, patients starting a new chemotherapy regimen are referred to complete a pre-chemotherapy cancer rehabilitation evaluation (i.e., prehab) and invited to enroll in the ReVital-CORE program study. Once enrolled in ReVital-CORE, participants will complete a monthly online evaluation for 1 year. If frailty (or pre-frailty) is detected on any survey, physical or occupational therapy will be initiated for standard of care rehabilitation evaluation and treatment.

Key facts

Study ID

NCT04852575

Run by

Kessler Foundation

People needed

141

Starts

2021-01-25

Expected to finish

2023-01-25

Last updated by the study team

2023-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18 years or older
• English speaking
• Starting new chemotherapy treatment with oncology partner
• Provide informed consent

You may not qualify if…

• Eligible for hospice care

Where it is running

• Kessler Institute for Rehabilitation — West Orange, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.